One year after the first cases of COVID-19 were diagnosed in North America, vaccines from Pfizer, AstraZeneca and Moderna are on the verge of becoming widely available.
And while IBEW members are not the scientists creating those vaccines, they have been nearly as integral to the discovery, production and distribution process as any biochemist or virologist on the planet.
From decades of building and maintaining pharmaceutical research labs to setting up new production facilities practically overnight, IBEW tradesmen and tradeswomen have been at the forefront of the pandemic response from its earliest days, and their efforts — along with those countless others around the world — have brought us to the verge of a monumental breakthrough that will save countless lives and restore order after a year of COVID-19 chaos.
"Without a doubt the vaccine that will end this scourge has and will be brought to you by the skilled craft unions. They are every bit as important as the person working at the lab bench they built," said Tim Dickson, director of the Pharmaceutical Industry Labor-Management Association.
The vaccines from Pfizer, AstraZeneca and Moderna are scientific achievements with few parallels in human history, victories won by researchers and the craft and trade workers who know how to take their ideas and transform them into enough medicine to heal an entire world.
According to a 2018 PILMA study, union density in pharmaceutical jobs in the U.S. is 80-90%, and the reason is clear: quality.
"It's intuitive. Millions of lives and billions of dollars hang on the effectiveness, the reliability of these facilities. These clean rooms and fume hoods — there are tons of inert and active molecules. You can't go cheap," Dickson said. "You don't go to Piggly Wiggly and get day workers to build a clean room." |